Development of animal models for schizophrenia

DMM Disease Models and Mechanisms

Volumn 3, Issue 1-2, 2010, Pages 22-26

  Arguello, P Alexander ^a   Markx, Sander ^a   Gogos, Joseph A ^a   Karayiorgou, Maria ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE;

ADULT; ANIMAL MODEL; CASE REPORT; CHROMOSOME 11; CHROMOSOME 16; CHROMOSOME 22Q; CHROMOSOME DELETION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; GENE DELETION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CHROMOSOME; MALE; MICRODELETION; MOUSE; NONHUMAN; ORTHOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; TREATMENT RESPONSE;

ANIMALS; DISEASE MODELS, ANIMAL; MICE; PHENOTYPE; SCHIZOPHRENIA;

ANIMALIA;

EID: 77649210967     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.003996     Document Type: Review

References (36)

1. Arguello, P. A. and Gogos, J. A. (2006). Modeling madness in mice: one piece at a time. Neuron 52, 179-196.
2. Beckmann, J. S., Estivill, X. and Antonarakis, S. E. (2007). Copy number variants and genetic traits: closer to the resolution of phenotypic to genotypic variability. Nat. Rev. Genet. 8, 639-646.
3. Burmeister, M., McInnis, M. G. and Zöllner, S. (2008). Psychiatric genetics: progress amid controversy. Nat. Rev. Genet. 9, 527-540.
4. DSM-IV-TR (2000). Diagnostics and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. Arlington, VA: American Psychiatric Association.
5. Feuk, L., Carson, A. R. and Scherer, S. W. (2006). Structural variation in the human genome. Nat. Rev. Genet. 7, 85-97.
6. Freedman, R. (2003). Schizophrenia. N. Engl. J. Med. 349, 1738-1749.
7. Iafrate, A. J., Feuk, L., Rivera, M. N., Listewnik, M. L., Donahoe, P. K., Qi, Y., Scherer, S. W. and Lee, C. (2004). Detection of large-scale variation in the human genome. Nat. Genet. 36, 949-951.
8. International Schizophrenia Consortium (2008). Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455, 237-241.
9. Karayiorgou, M. and Gogos, J. (1997). A turning point in schizophrenia genetics. Neuron 19, 967-979.
10. Karayiorgou, M., Morris, M. A., Morrow, B., Shprintzen, R. J., Goldberg, R., Borrow, J., Gos, A., Nestadt, G., Wolyniec, P. S., Lasseter, V. K. et al. (1995). Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc. Natl. Acad. Sci. USA 92, 7612-7616.
11. Kimber, W. L., Hsieh, P., Hirotsune, S., Yuva-Paylor, L., Sutherland, H. F., Chen, A., Ruiz-Lozano, P., Hoogstraten-Miller, S. L., Chien, K. R., Paylor, R. et al. (1999). Deletion of 150 kb in the minimal DiGeorge/velocardiofacial syndrome critical region in mouse. Hum. Mol. Genet. 8, 2229-2237.
12. Kirov, G., Grozeva, D., Norton, N., Ivanov, D., Mantripragada, K. K., Holmans, P., International Schizophrenia Consortium, Wellcome Trust Case Control Consortium, Craddock, N., Owen, M. J. et al. (2009). Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum. Mol. Genet. 18, 1497-1503.
13. Koike, H., Arguello, P. A., Kvajo, M., Karayiorgou, M. and Gogos, J. A. (2006). Disc1 is mutated in the 129S6/SvEv strain and modulates working memory in mice. Proc. Natl. Acad. Sci. USA 103, 3693-3697.
14. Lee, J. A. and Lupski, J. R. (2006). Genomic rearrangements and gene copy-number alterations as a cause of nervous system disorders. Neuron 52, 103-121.
15. Lewis, D. A. and Lieberman, J. A. (2000). Catching up on schizophrenia: natural history and neurobiology. Neuron 28, 325-334.
16. Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S., Davis, S. M., Davis, C. E., Lebowitz, B. D. et al. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N. Engl. J. Med. 353, 1209-1223.
17. Long, J. M., LaPorte, P., Merscher, S., Funke, B., Saint-Jore, B., Puech, A., Kucherlapati, R., Morrow, B. E., Skoultchi, A. I., Wynshaw-Boris, A. et al. (2006). Behavior of mice with mutations in the conserved region deleted in velocardiofacial/DiGeorge syndrome. Neurogenetics 7, 247-257.
18. McCarthy, S. E., Makarov, V., Kirov, G., Addington, A. M., McClellan, J., Yoon, S., Perkins, D. O., Dickel, D. E., Kusenda, M., Krastoshevsky, O. et al. (2009). Microduplications of 16p11.2 are associated with schizophrenia. Nat. Genet. 41, 1223-1227.
19. Mukai, J., Dhilla, A., Drew, L. J., Stark, K. L., Cao, L., MacDermott, A. B., Karayiorgou, M. and Gogos, J. A. (2008). Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion. Nat. Neurosci. 11, 1302-1310.
20. Murphy, K. C., Jones, L. A. and Owen, M. J. (1999). High rates of schizophrenia in adults with velo-cardiofacial syndrome. Arch. Gen. Psych. 56, 940-945.
21. Paterlini, M., Zakharenko, S. S., Lai, W. S., Qin, J., Zhang, H., Mukai, J., Westphal, K. G., Olivier, B., Sulzer, D., Pavlidis, P. et al. (2005). Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice. Nat. Neurosci. 8, 1586-1594.
22. Paylor, R., McIlwain, K. L., McAninch, R., Nellis, A., Yuva-Paylor, L. A., Baldini, A. and Lindsay, E. A. (2001). Mice deleted for the DiGeorge/velocardiofacial syndrome region show abnormal sensorimotor gating and learning and memory impairments. Hum. Mol. Genet. 10, 2645-2650.
23. Paylor, R., Glaser, B., Mupo, A., Ataliotis, P., Spencer, C., Sobotka, A., Sparks, C., Choi, C. H., Oghalai, J., Curran, S. et al. (2006). Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc. Natl. Acad. Sci. USA 103, 7729-7734.
24. Powell, S. B., Zhou, X. and Geyer, M. A. (2009). Prepulse inhibition and genetic mouse models of schizophrenia. Behav. Brain Res. 204, 282-294.
25. Pulver, A. E., Nestadt, G., Goldberg, R., Shprintzen, R. J., Lamacz, M., Wolyniec, P. S., Morrow, B., Karayiorgou, M., Antonarakis, S. E., Housman, D. et al. (1994). Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J. Nerv. Ment. Dis. 182, 476-478.
26. Redon, R., Ishikawa, S., Fitch, K. R., Feuk, L., Perry, G. H., Andrews, T. D., Fiegler, H., Shapero, M. H., Carson, A. R., Chen, W. et al. (2006). Global variation in copy number in the human genome. Nature 444, 444-454.
27. Rujescu, D., Ingason, A., Cichon, S., Pietiläinen, O. P., Barnes, M. R., Toulopoulou, T., Picchioni, M., Vassos, E., Ettinger, U., Bramon, E. et al. (2009). Disruption of the neurexin 1 gene is associated with schizophrenia. Hum. Mol. Genet. 18, 988-996.
28. Sebat, J., Lakshmi, B., Troge, J., Alexander, J., Young, J., Lundin, P., Månér, S., Massa, H., Walker, M., Chi, M. et al. (2004). Large-scale copy number polymorphism in the human genome. Science 305, 525-528.
29. Shi, J., Levinson, D. F., Duan, J., Sanders, A. R., Zheng, Y., Pe'er, I., Dudbridge, F., Holmans, P. A., Whittemore, A. S., Mowry, B. J. et al. (2009). Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460, 753-757.
30. Stark, K. L., Xu, B., Bagchi, A., Lai, W.-S., Liu, H., Hsu, R., Wan, X., Pavlidis, P., Mills, A. A., Karayiorgou, M. et al. (2008). Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat. Genet. 40, 751-760.
31. Stefansson, H., Rujescu, D., Cichon, S., Pietiläinen, O. P., Ingason, A., Steinberg, S., Fossdal, R., Sigurdsson, E., Sigmundsson, T., Buizer-Voskamp, J. E. et al. (2008). Large recurrent microdeletions associated with schizophrenia. Nature 455, 232-236.
32. Stefansson, H., Ophoff, R. A., Steinberg, S., Andreassen, O. A., Cichon, S., Rujescu, D., Werge, T., Pietiläinen, O. P., Mors, O., Mortensen, P. B. et al. (2009). Common variants conferring risk of schizophrenia. Nature 460, 744-747.
33. Walsh, T., McClellan, J. M., McCarthy, S. E., Addington, A. M., Pierce, S. B., Cooper, G. M., Nord, A. S., Kusenda, M., Malhotra, D., Bhandari, A. et al. (2008). Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320, 539-543.
34. Webber, M. A. and Marder, S. R. (2008). Better pharmacotherapy for schizophrenia; what does the future hold? Curr. Psychiatry Rep. 10, 352-358.
35. Xu, B., Roos, J. L., Levy, S., van Rensburg, E. J., Gogos, J. A. and Karayiorgou, M. (2008). Strong association of de novo copy number mutations with sporadic schizophrenia. Nat. Genet. 40, 880-885.
36. Xu, B., Woodroffe, A., Rodriguez-Murillo, L., Roos, J. L., van Rensburg, E. J., Abecasis, G. R., Gogos, J. A. and Karayiorgou, M. (2009). Elucidating the genetic architecture of familial schizophrenia using rare copy number variant and linkage scans. Proc. Natl. Acad. Sci. USA 106, 16746-16751.